Safety and Efficacy Study of QR-333 in Patient's With Symptomatic Diabetic Neuropathy
- First Posted Date
- 2007-12-05
- Last Posted Date
- 2009-01-08
- Lead Sponsor
- Quigley Pharma, Inc.
- Target Recruit Count
- 140
- Registration Number
- NCT00568035
- Locations
- 🇺🇸
Renstar Medical Research, Ocala, Florida, United States
🇺🇸Rwjms/Umdnj, New Brunswick, New Jersey, United States
🇺🇸Hartwell Research Group / Anderson Family Care, Anderson, South Carolina, United States
© Copyright 2025. All Rights Reserved by MedPath